The tumor suppressor gene hypermethylated in cancer 1 (HIC1), located on human chromosome 17p13.3, is frequently silenced in cancer by epigenetic mechanisms. Hypermethylated in cancer 1 belongs to the bric a`brac/ poxviruses and zinc-finger family of transcription factors and acts by repressing target gene expression. It has been shown that enforced p53 expression leads to increased HIC1 mRNA, and recent data suggest that p53 and Hic1 cooperate in tumorigenesis. In order to elucidate the regulation of HIC1 expression, we have analysed the HIC1 promoter region for p53-dependent induction of gene expression. Using progressively truncated luciferase reporter gene constructs, we have identified a p53-responsive element (PRE) 500 bp upstream of the TATA-box containing promoter P0 of HIC1, which is sequence specifically bound by p53 in vitro as assessed by electrophoretic mobility shift assays. We demonstrate that this HIC1 p53-responsive element (HIC1.PRE) is necessary and sufficient to mediate induction of transcription by p53. This result is supported by the observation that abolishing endogenous wild-type p53 function prevents HIC1 mRNA induction in response to UV-induced DNA damage. Other members of the p53 family, notably TAp73b and DNp63a, can also act through this HIC1.PRE to induce transcription of HIC1, and finally, hypermethylation of the HIC1 promoter attenuates inducibility by p53.
Introduction
The gene hypermethylated in cancer 1(HIC1), located in a region telomeric to TP53 on the short arm of chromosome 17 (17p13.3), encodes for a sequencespecific transcriptional repressor with five C2H2 zincfingers, and an N-terminal broad complex, tramtrack, and bric a`brac/poxviruses and zinc-finger proteinprotein interaction domain (Wales et al., 1995; Deltour et al., 1999; Pinte et al., 2004b) . Enforced expression of HIC1 alters cellular differentiation and reduces clonogenic growth of cultured cancer cells, pointing to a possible tumor suppressive role (Wales et al., 1995) . In mouse knockout studies, heterozygous disruption of Hic1 leads to the formation of cancers in a genderspecific way, with heterozygous male mice developing carcinomas, and females predominantly lymphomas and sarcomas (Chen et al., 2003) . Interestingly, in this model the remaining Hic1 allele was epigenetically silenced through hypermethylation of its promoter region, but not mutated. These studies underscore the importance of maintaining sufficient HIC1 protein levels in cells via controlled regulation. Consistent with the mouse-model findings, the HIC1 gene has been shown to be epigenetically silenced in a wide variety of human malignancies, such as breast cancer (Fujii et al., 1998) , colorectal cancer (Ahuja et al., 1997) and hematopoietic neoplasms (Issa et al., 1997) .
The human HIC1 genomic region contains three promoters that give rise to different alternatively spliced HIC1 transcripts (Pinte et al., 2004a) . The minor TATA-box containing promoter P0 is associated with exon 1b, whereas an upstream major GC-rich promoter P1 is associated with exon 1a. Exon 1c as well as internally spliced exons 1d and 1e are transcribed from P2, another upstream promoter containing GC boxes. Of the alternative first exons, only exon 1b is potentially coding and the common open reading frame of HIC1 resides within the large exon 2 coding region. The complexity of the HIC1 promoter and transcriptional organization might imply that the cell tightly controls regulation of HIC1 expression. However, little has been reported on transcriptional control of HIC1. A previous report has implicated potential p53 regulation of HIC1 based on demonstration of a putative p53 binding site located approximately 4 kb upstream of the exon 1a TATA-box (Wales et al., 1995) and increased HIC1 transcript expression over basal levels upon ectopic p53 expression was observed (Wales et al., 1995; Guerardel et al., 2001) . Given the importance of HIC1 in maintaining tumor suppression and the paucity of information on HIC1 transcriptional control, we investigated the precise role of p53 in the control of HIC1 regulation.
In the current report, we describe a conserved, HIC1 p53-responsive element (HIC1.PRE) located 500 bp upstream of the P0 promoter and document that this site is essential in p53-induced HIC1 expression. That p53 is critical for basal and increased HIC1 expression is further shown by p53 knockdown studies. Interestingly, the HIC1.PRE can also bind and support regulation by other p53 family members, notably TAp73b and DNp63a, and hypermethylation of the HIC1 promoter region impairs inducibility by p53. Our studies demonstrate the importance of a direct p53 control of HIC1 regulation, implicating HIC1 as a downstream target of p53.
Results

Exogenous p53 upregulates HIC1
We transfected the p53-deficient cell lines Saos-2 and H1299 with an HA-tagged expression plasmid for p53 and assessed changes in HIC1 mRNA levels using realtime quantitative reverse transcription-PCR (RQ-PCR). In p53-transfected H1299 cells, HIC1 mRNA was induced 40-fold as compared to cells transfected with the p53-deficient pcDNA3 empty vector. Similar experiments using Saos-2 cells led to a twofold induction, confirming that HIC1 expression is positively regulated by exogenous p53 at the mRNA level (Wales et al., 1995; Guerardel et al., 2001) . Moreover, induction of HIC1 mRNA by exogenous p53 was confirmed in normal human fibroblasts (BJ cells) carrying a temperaturesensitive mutant p53
Val135 (BJ.tsp53 cells; Sun et al., 1998) , which is only active at 321C. After a culture period of 24 h at the permissive temperature, HIC1 mRNA was induced threefold over the expression seen in cells cultured at the nonpermissive temperature. Successful activation of p53 was confirmed by measuring mRNA expression of BBC3/PUMA, a well-established p53 target gene (Nakano and Vousden, 2001) , as a surrogate marker (ninefold induction) (Figure 1a ).
An earlier report described a potential p53 binding site 4 kb upstream of the P0 promoter (HIC1.PRE.4 kb) based on sequence analyses (Wales et al., 1995) . In order to test the activity of this particular site, we used this sequence to replace the previously characterized PRE in the DNp73 minimal promoter, as DNp73 was shown to be a p53 target (Grob et al., 2001) . Two additional promoter constructs served as controls: the unmanipulated minimal DNp73 promoter to assess basal activity and a DNp73 hybrid promoter containing the PRE from the CDKN1a/p21
gene promoter (DNp73-p21.PRE) as a positive control. All promoter constructs were cloned into the pGL3-basic luciferase reporter vector (Figure 1b) . The constructs were co-transfected with the HA-tagged expression plasmid for p53 into Saos-2 cells. Luciferase activity was determined and compared to the activity observed in Saos-2 cells cotransfected with the pcDNA3 empty vector. A 550-fold induction of the minimal DNp73 promoter and an 800-fold induction of the DNp73-p21.PRE hybrid promoter were detected, confirming the activation by p53. In contrast, only a 0.8-fold induction of luciferase activity was observed with the DNp73-HIC1.PRE.4 kb hybrid luciferase reporter, where the DNp73 p53 binding site was replaced by the HIC1.PRE.4 kb sequence (Figure 1c ). Given our findings that the proposed (Grob et al., 2001) ; numbers in brackets refer to the genomic sequence AL136528.11. Sequences of p21.PRE and HIC1.-PRE.4 kb are as described (Wales et al., 1995; Qian et al., 2002) . (c) Luciferase reporter gene assays in Saos-2 cells transfected with wild-type p53. Bars indicate n-fold relative luciferase activity (RLA) with respect to pcDNA3 mock-transfected cells. pGL3 is the empty vector control. Experiments were performed in triplicates; error bars represent standard deviations. p53 directly regulates HIC1 C Britschgi et al HIC1.PRE.4 kb is not capable of conferring p53 induction of transcription, we set out to analyse the mechanisms of p53-induced HIC1 upregulation in more detail.
A conserved, PRE resides in the proximal promoter region of the human HIC1 gene The organization of the HIC1 gene promoter is schematically shown in Figure 2a (Pinte et al., 2004a) . To evaluate the p53-mediated activation of HIC1 expression, we cloned 3 kb of the HIC1 promoter region, comprising all three described HIC1 promoters into the pGL3-basic luciferase reporter vector (pGL3.HIC1prm.1). Co-transfection with p53 in Saos-2 leads to a fivefold induction of the reporter construct, as compared to co-transfection with the pcDNA3 empty vector (Figure 2b ). By testing progressively truncated promoter reporter constructs (pGL3.HIC1prm.2-6) in this experimental setting, a 124 bp region, located 500 bp upstream of the transcriptional start site of the promoter p53 directly regulates HIC1 C Britschgi et al P0, was identified, which is necessary to mediate induction by p53 ( Figure 2b ). In a next step, this 124 bp fragment was cloned into the pGL3-basic vector (pGL3.HIC1prm.4-5) and induction by p53 was assessed in co-transfection experiments as described above. We found a 40-fold induction by p53, showing that a PRE must be located within this region, which is not only necessary but also sufficient to mediate p53 induction ( Figure 2c ). The p53 consensus binding site (p53CON) consists of RRRCWWGYYY, where R is a purine, W is adenosine or thymidine and Y is a pyrimidine (el-Deiry et al., 1992) . A typical PRE comprises at least two repeats of p53CON, usually separated by only few spacing base pairs. Sequence analysis revealed four repeats of this motif at positions 59-124 of the 124 bp fragment, with an overall 80% similarity to the published consensus binding site ( Figure 2d ). We next isolated this minimal promoter construct of 66 bp, comprising the four p53CON and just a few adjacent base pairs and cloned it into the luciferase reporter vector (pGL3.HIC1.PRE). In Saos-2 cells, this minimal promoter was equally inducible by p53 in the reporter gene assay as the parental 124 bp fragment (Figure 2c ), and thus represents the PRE in the HIC1 promoter. We then generated two mutant minimal promoter constructs to inactivate the potential p53 binding sites. In the first mutant, three of the four binding sites were mutated by replacing the crucial CWWG core sequence with a row of adenosine bases described to prevent p53 binding, pGL3.HIC1.-PRE.mut (Ruiz de Almodovar et al., 2004) (Figure 2d ). In the second mutant, only the first of the four p53CON was inactivated by replacing the central C and G to A (pGL3.HIC1.prm.4-5.mut) (Figure 2d ). In the cotransfection assays, these HIC1 promoter mutants could no longer be induced by p53, pointing to a direct effect of p53 onto the HIC1 promoter (Figure 2c ).
BLAST comparison revealed that HIC1.PRE and the surrounding promoter region are highly conserved in position and sequence among different species (Figure 2e ). p53 protein binds to HIC1.PRE in vitro We next conducted electrophoretic mobility shift assays (EMSA) to assess binding of p53 protein to the identified HIC1.PRE. As radioactively labeled probes, we used the 66 bp minimal-responsive sequence HIC1.PRE identified in the reporter gene assays (HIC1.PRE) and a positive control sequence consisting of two perfect p53 consensus binding sites (2 Â p53CON) (Wolcke et al., 2003) . The mouse monoclonal antibody PAb421 directed against the C-terminal end of p53 has been shown to be necessary for efficient sequence-specific DNA binding of p53 in vitro and was therefore included in the assay (Wolcke et al., 2003) . In vitro-transcribed and -translated HA-tagged p53 protein activated by PAb421 was found to bind the positive control probe leading to a gel shift (Figure 3a , lane 5), and addition of a monoclonal antibody directed against the N-terminal end of p53 (DO-1) led to a supershift of the complex (Figure 3a, lane 7) . In contrast, addition of a 300-fold molar excess of cold probe was efficiently competing the shift (Figure 3a, lane 6) . Similarly, mockprogrammed reticulocyte lysate using pcDNA3 empty vector failed to show any shifts (Figure 3a , lanes 2 and 3), as did p53 without addition of PAb421 (Figure 3a , lane 4). The HIC1.PRE probe followed exactly the same pattern, with a band shift by activated p53 and a supershift after addition of the DO-1 antibody (Figure 3a, lanes 12 and 14) . Competition with p53 directly regulates HIC1 C Britschgi et al increasing amounts of cold probe efficiently abrogated both shift and supershift (Figure 3b and c, lanes 2-4), whereas competition with cold mutated probe did not (Figure 3b and c, lanes 5-7, see Figure 2d for sequence). Western blotting of the programmed reticulocyte lysates confirmed sufficient production of p53 (Figure 3d ). Taken together, these results show that p53 sequence specifically binds to HIC1.PRE in vitro.
Endogenous wild-type p53 activates transcription of HIC1 mRNA The human breast adenocarcinoma cell line MCF7 has been shown to activate endogenous wild-type p53 in response to UV-induced DNA damage, leading to increased expression of p53 target genes (Obad et al., 2004) . To examine whether under this condition endogenous p53 is inducing HIC1 mRNA expression, we UV-irradiated MCF7 cells and assessed HIC1 mRNA changes by RQ-PCR. Hypermethylated in cancer 1 message was 14-fold upregulated 8 h after irradiation, which is consistent with rapid stabilization and activation of p53 following DNA damage (Figure 4 ). Activation of p53 was confirmed by measuring BBC3/ PUMA, and CDKN1a encoding for p21
. As a negative control, we irradiated the p53À/À H1299 cell line, and we could neither detect HIC1 mRNA induction nor induction of the two above-mentioned target genes.
To demonstrate the necessity of p53 in the response, we generated an MCF7 cell line stably expressing a short hairpin RNA (shRNA) suitable to silence p53 mRNA expression, MCF7.hygro.shp53, using a lentiviral vector (Voorhoeve and Agami, 2003) , and a control cell line containing the lentiviral vector without the shRNA, MCF7.hygro. Western blot analysis of irradiated MCF7.hygro and MCF7.hygro.shp53 confirmed that p53 was activated and stabilized in the control cell line after UV irradiation. In contrast, only minimal levels of p53 could be detected in MCF7 cells expressing the shRNA targeting p53 24 h after irradiation. These results demonstrate that the chosen shRNA sequence efficiently knocked down p53 protein production ( Figure 5a ).
In UV-irradiated MCF7.hygro cells, HIC1 mRNA was induced 12-fold 8 h after irradiation and threefold after 24 h. CDKN1a/p21 WAF1/CIP1 and BBC3/PUMA mRNAs showed similar patterns of induction (Figure 5b ). In contrast, after UV irradiation of MCF7.hygro.shp53 cells, no induction of HIC1 and the other two p53 target genes could be observed (Figure 5b ). Taken together, these findings show that endogenous wild-type p53 is required for transcription of HIC1 message in response to UV-induced DNA damage.
HIC1.PRE is responsive to other members of the p53 family During the last decade, it has become apparent that there are two homologs to p53 together constituting the so-called 'p53 family': p63 and p73. They share homology with p53 in the major domains such as the amino-terminal transactivation domain (TA), the oligomerization domain and most pronounced in the central DNA-binding domain (DBD). p63 and p73 can be expressed as numerous different variants through alternative splicing of 3 0 exons (giving rise to a and b variants and others) and through the use of alternative promoters giving rise to N-terminal truncated DN variants that lack the TA and can thus interfere with the function of the full-length family members (Grob et al., 2001 , reviewed in Melino et al., 2002 . However, DN variants have also been shown to have direct transcriptional activity (Liu et al., 2004a; Wu et al., 2005) . Importantly p63 and p73 have been shown to bind directly to PREs and regulate target gene expression (Marin et al., 1998; Di Como et al., 1999) . To determine whether HIC1 belongs to the genes that represent possible target genes for different members of the p53 family, we transiently transfected H1299 cells, which are p53 deficient and express very low p73 protein (Fontemaggi et al., 2002) with expression plasmids for p53, full-length TAp73a and b, N-terminal truncated DNp73a and b, and TAp63a and DNp63a, and we Figure 4 Endogenous wild-type p53 induces HIC1 mRNA. MCF7 (wt-p53 þ / þ ) and H1299 cells (p53À/À) were either untreated (empty bars) or UV irradiated at 10 mJ/cm 2 (gray bars). HIC1 (top graphs), CDKN1a/p21 WAF1/CIP1 (middle graphs) and BBC3/PUMA (bottom graphs) mRNA levels are indicated as nfold increase after UV irradiation with respect to nonirradiated cells, using Abl as a reference gene. Experiments were performed in duplicates; error bars represent standard deviations.
p53 directly regulates HIC1
C Britschgi et al assessed changes in HIC1 mRNA levels by RQ-PCR 36 h after transfection (Figure 6a ). Transfection efficiency was corroborated by fluorescence microscopy of a sample transfected in parallel with EGFP (>70% GFP positives). Transfection of p53 resulted in the highest induction of HIC1 mRNA, the other family members being significantly less efficient in inducing HIC1 expression. Nevertheless, TAp73b and DNp63a were also capable of promoting HIC1 transcription. In order to verify the binding capacity of the different p53 family members, we co-transfected the above-mentioned members with the luciferase reporter vector containing the 66 bp HIC1.PRE into H1299 cells and measured luciferase activity (Figure 6b) . Basically, the observed pattern of differential induction was the same as observed for the accumulation of HIC1 mRNA, with p53 being the strongest inducer of transcription. Efficient induction of pGL3.HIC1.PRE was also observed with TAp73b, whereas less stimulation was obtained with DNp63a and TAp73a. These results indicate that HIC1 is primarily a p53 target gene, but can also be directly transactivated by selected p53 family members.
Demethylation of the HIC1 promoter enhances induction by p53
As the HIC1 gene has been extensively studied for epigenetic silencing by promoter hypermethylation, one wonders whether inducibility by p53 could be affected by CpG hypermethylation. The human colorectal cancer cell line HCT116 has been shown to have a hypermethylated HIC1 promoter region, which can be demethylated using 5-aza-2 0 -deoxycytidine (5-Aza-dC) (Arnold et al., 2003) . Accordingly, treatment of the isogenic p53À/À derivative of HCT116 (HCT116 p53À/À) (Bunz et al., 1998) for 2 days resulted in a dosedependent upregulation of HIC1 mRNA (Figure 7 ). After demethylation for 2 days, the cells were transiently transfected with the p53-HA expression vector or pcDNA3 and mRNA levels were measured 24 h later to compare induction of HIC1 mRNA by p53 on a methylated and a demethylated HIC1 promoter. Hypermethylated in cancer 1 mRNA induction by 5-AzadC was continuing after 3 days of treatment and enhanced by co-transfection with p53-HA (Figure 7 , compare lanes '3d þ pcDNA3' and '3d þ p53'). Normalization of the measured values for p53 to their respective pcDNA3 values revealed that HIC1 mRNA induction by p53 was between 4.0 to 6.3 fold in 5-Aza-dC-treated cells, but only 2.0-fold in DMSO mock-treated HCT116 p53À/À. These findings suggest that hypermethylation of the HIC1 promoter region attenuates induction by p53.
Discussion
Our results demonstrate that p53 directly induces transcription of the HIC1 locus via a conserved PRE (HIC1.PRE) in the proximal HIC1 promoter region, which is located some 500 bp upstream of the promoter P0, containing the TATA-box. Hypermethylated in cancer 1 p53-responsive element meets the sequence requirements of a PRE, with 80% homology to the p53 consensus binding site motif (el-Deiry et al., 1992) . This element mediates specific and direct transcriptional induction by p53, as inactivating mutations abrogate induction by p53, and activated p53 binds sequence specifically to HIC1.PRE in vitro.
The location of HIC1.PRE between the major GCrich promoter P1 and the minor TATA-box promoter P0 suggests a role of p53 in regulating the two major alternative transcripts, namely the one originating from the P1 promoter (exon 1a transcript) and the other WAF1/CIP1 and BBC3/ PUMA mRNA levels are indicated as n-fold induction as described in Figure 4. p53 directly regulates HIC1 C Britschgi et al generated by the P0 promoter (exon 1b transcript). Both transcripts are equally responsive to p53 (Guerardel et al., 2001) . We propose that the HIC1.PRE serves as an intronic responsive element for exon 1a transcription and as a promoter-bound responsive element for exon 1b transcription. Functional intronic PREs have been well documented in a variety of biological systems (Liu et al., 2004b; Ruiz de Almodovar et al., 2004) . The fact that all truncated promoter constructs containing the HIC1.PRE exhibit approximately the same activity suggests that no other PREs are located in the 2.9 kb sequence analysed. We cannot, however, exclude that other sites may exist further upstream.
Consistent with the notion that p53 is a necessary, positive regulator of HIC1, activation of endogenous p53 by UV irradiation induced HIC1 mRNA, and HIC1 induction was completely abrogated when p53 was silenced by RNA interference. Upon UV irradiation, wild-type MCF7 cells displayed characteristics of apoptosis, whereas MCF7 cells expressing the p53-shRNA developed fibroblast-like features and showed less apoptosis, supporting the inactivation of p53. It is conceivable that HIC1 plays a role in the p53-dependent apoptosis circuitry in response to DNA damage. The fact that enforced HIC1 expression leads to growth arrest and reduced survival of cultured tumor cells supports our hypothesis (Wales et al., 1995) . Our observation that p53 is regulating HIC1 in MCF7 cells is in contrast to an earlier report describing that HIC1 is neither expressed in untreated MCF7 cells nor induced by p53 (Wales et al., 1995) . These differences may be explained by the documented phenotypic variability of MCF7 cell clones grown in different laboratories (Bahia et al., 2002) .
The p53 family members p63 and p73 share high homology to p53, especially in the central DBD, and act as transcription factors not only for a number of p53-responsive genes (Marin et al., 1998; Di Como et al., 1999) but also for distinct sets of target genes (reviewed in Melino et al., 2002; Benard et al., 2003; Moll and Slade, 2004) . Interestingly, the p53 family members TAp73b and DNp63a were also capable of transactivating HIC1. This suggests that in certain cell types, HIC1 may be regulated by these p53 family members. Despite the strong structural and partial functional similarity, the different p53 family proteins exert strikingly diverse biological functions. In particular, p63 and p73 exert more pronounced effects on cellular differentiation and development than p53 (reviewed in Moll and Slade, 2004) , and thus it will be interesting to determine the biological significance of the p53 family members in HIC1 regulation. p53 directly regulates HIC1 C Britschgi et al Epigenetic silencing of tumor suppressor genes plays an important role in tumor initiation and progression (reviewed in Jones and Baylin, 2002) , and especially the HIC1 gene has been extensively studied and found to be silenced by pathological promoter hypermethylation in a wide variety of human malignancies. Moreover, in the heterozygous knockout mouse model, it has been observed that the remaining wild-type allele was inactivated in the tumor tissue by promoter hypermethylation rather than by mutation (Chen et al., 2003) , suggesting that epigenetic silencing leads to a profound disturbance of HIC1 regulation and function. Our results in HCT116 p53À/À suggest that p53 control of HIC1 function might be delicately attenuated by pathological hypermethylation of the HIC1 promoter region and thus represent one important example of epigenetically disturbed HIC1 regulation.
Recent studies in a double-heterozygous knockout mouse model implicate cooperation between p53 and Hic1 in tumorigenesis leading to aggressive cancer progression (Chen et al., 2004) . In addition, a survey of sporadic breast cancer revealed a similar synergistic effect combining loss of HIC1 expression and p53 malfunction (Nicoll et al., 2001) . Moreover, it has been recently reported that sirtuin-1 (SIRT1), the human homolog of the yeast silent information regulator 2a, is negatively regulated by HIC1 at the transcriptional level (Chen et al., 2005) . Sirtuin-1 is a class III deacetylase, which negatively regulates p53 at the post-translational level (Luo et al., 2001; Vaziri et al., 2001) . Integrating our findings with this recent report suggests that HIC1 and SIRT1 cooperate in a positive feedback loop geared towards fine-tuning of p53 function. This would imply an additional level of regulation in the p53-SIRT1 pathway, as p53 can directly bind to and repress the SIRT1 promoter (Nemoto et al., 2004) .
In conclusion, we have characterized HIC1.PRE, a PRE in the HIC1 gene, which is necessary and sufficient for the direct regulation by p53, identifying HIC1 as a p53 downstream target. This strong link between p53 and HIC1 opens up a new cellular pathway regulating cellular growth, apoptosis and differentiation.
Materials and methods
Cell lines and transient transfections
The human osteosarcoma cell line Saos-2, the human nonsmall-cell lung cancer cell line NCI-H1299 and the human mammary gland adenocarcinoma cell line MCF7 were obtained from ATCC (LGC Promochem, Molsheim, France). Exponentially growing Saos-2 and H1299 cells were transiently transfected using Amaxa's Nucleofector kit (Amaxa GmbH, Cologne, Germany). Transfection efficiency was assessed by parallel transfections with the GFP expression vector pEGFP-N1 (Clontech Laboratories AG, Basel, Switzerland). The human colorectal cancer cell line HCT116 p53À/À (a kind gift from Dr B Vogelstein) was treated with 5-Aza-dC (SigmaAldrich, Fluka Chemie GmbH, Buchs, Switzerland) in DMSO for 2 days as indicated, and then transfected using Lipofectamine 2000 (Invitrogen, Basel, Switzerland) according to the manufacturer's protocol without replacing the 5-Aza-dC medium.
Lentiviral vector construction, preparation of vector stocks and transduction of MCF7 cells Hygromycin B resistance or the combined p53 shRNA/ hygromycin B resistance expression cassettes were generated by PCR using pRS-hygro/pRS-hygro p53 no. 2 plasmid templates (kindly provided by Dr R Agami) (Voorhoeve and Agami, 2003) . Polymerase chain reaction fragments were ligated into the pCR-XL-TOPO vector (Invitrogen), then subcloned into the XhoI site of HIV vector pCR-XL-CSPre (Tschan et al., 2003) to create pCR-XL-CS-hygro and pCR-XL-CS-shp53hygro, respectively. Vesicular stomatitis virus (VSV)-G-pseudotyped lentiviral supernatant was generated by transient transfection using the transfer vectors pCR-XL-CShygro or pCR-XL-CS-shp53hygro and the third-generation packaging system (VSV-G-expressing plasmid pMD.G, gagand pol-expressing pMDLg/p.RRE and rev-expressing pRSVRev plasmids) as described (Galimi et al., 2002; Tschan et al., 2003) .
MCF7 cells were transduced overnight in the presence of 8 mg/ml polybrene using lentivirus at an MOI of 10. The transduction was repeated once, and 2 days later, polyclonal pools were selected for 10 days with 250 mg/ml hygromycin B (Roche Diagnostics AG, Rotkreuz, Switzerland), and selected cells were maintained in complete medium with 100 mg/ml hygromycin B.
Retroviral vectors and transduction of BJ cells
The retroviral vector WZL-p53
Val135 was obtained from Dr P Sun. Vector was generated as described (Sun et al., 1998) , and BJ cells were transduced in the presence of 8 mg/ml polybrene. Transduced cells were selected in the presence of 200 mg/ml hygromycin B.
Real-time quantitative reverse transcription-PCR Total RNA (1-2 mg) were reverse transcribed using pd(N)6 random primers (Roche Diagnostics). Polymerase chain reaction and fluorescence detection were performed using the ABI PRISM 7700 Sequence Detection System (Applied Biosystems, Rotkreuz, Switzerland). For quantification of HIC1, BBC3/PUMA and CDKN1a/p21 WAF1/CIP1 cDNA, 1 Â Taqman Gene Expression Assay was used (Applied Biosystems, Assay ID Hs00359611_s1, Hs00248075_m1 and Hs00355782_m1, respectively). For PBGD, we used 5 0 -GGC AATGCGGCTGCAA-3 0 as forward primer and 5 0 -GGGTA CCCACGCGAATCAC-3 0 as reverse primer, both at 300 nM, and 5 0 -FAM-CTCATCTTTGGGCTGTTTTCTTCCGCCT-TAMRA-3 0 as fluorescent probe at 200 nM. For Abl, 5 0 -TG GAGATAACACTCTAAGCATAACTAAAGGT-3 0 and 5 0 -GATGTAGTTGCTTGGGACCCA-3 0 were used as primers (900 nM) and 5 0 -FAM-CCATTTTTGGTTTGGGCTTCA CACCATT-TAMRA-3 0 as probe (200 nM) (Beillard et al., 2003) . All measurements were performed in duplicates and the arithmetic mean of the C t -values was used for calculations: target gene mean C t -values were normalized to the respective housekeeping gene mean C t -values (internal reference gene), and then to the experimental starting point (calibrator). To express mRNA levels as n-fold changes in regulation, 2 to the power of the obtained values was calculated (2 ÀDDCt method of relative quantification; Livak and Schmittgen, 2001 ).
Constructs and cloning
Expression plasmids for p53-HA, TAp73a-HA, TAp73b-HA, DNp73a-HA and DNp73b-HA were as described (Grob et al., p53 directly regulates HIC1 C Britschgi et al
